SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.66+2.8%Jan 30 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (9024)3/9/1999 1:04:00 PM
From: Webhead  Read Replies (1) of 17367
 
Hey lighten up BG! Just because someone isn't spouting the party line on this board don't jump on them and suggest hidden agendas. I too am worried that the trial just keeps on going and going and going. My perhaps mistaken understanding of the DSMB function is that they only stop a trial if safety concerns arise or there is a terriffic response rate. If (God forbid) BPI isn't reducing mortality relative to the placebo group then in the absence of safety issues the DSMB would not stop the trial. From the limited data we have I can only conclude that overall mortality is much lower than expected and that BPI can't be working great (like in the PII) or the trial would have already stopped. This is not to say that BPI won't be approved or offer a tremendous theraputic advantage but we have to stop relying on the PII results as an indication of efficacy since if BPI were still working that well the trial would have already been stopped.

BTW BG, I've been long Xoma for a few years so don't waste your time trying to dismiss my justifiable concerns by claiming that I have some hidden agenda. Besides, with my broker (and I'ld assume for the vast majority of people who read this board) you can't even short a stock as low as Xoma is now.

Ed
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext